Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Pharmacology|July 22, 2022
Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-LinkingLuyan Liu, Yi Wu, Kaiyan Ye, et al.Frontiers in Oncology|June 14, 2021
Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell AnalysisJingyu Zang, Kaiyan Ye, Yang Fei, et al.Virology Journal|July 31, 2020
SARS-CoV-2: characteristics and current advances in researchYicheng Yang, Zhiqiang Xiao, Kaiyan Ye, et al.International Journal of Biological Macromolecules|May 2, 2025
Customizable structured cellulose aerogel fibers by regulating regeneration rate for enhanced thermal insulationZirong Liu, Tingting Yang, Jing Zhou, et al.Frontiers in Microbiology|August 27, 2019
The Antiviral and Antitumor Effects of Defective Interfering Particles/Genomes and Their MechanismsYicheng Yang, Taibiao Lyu, Runing Zhou, et al.Cell Death and Differentiation|September 28, 2022
Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancerKaixuan Shi, Haijiao Lu, Zhenfeng Zhang, et al.Cancer Research|July 20, 2022
Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian CancerLin Cheng, Shichao Zhou, Shaoqing Zhou, et al.Cell Death & Disease|November 28, 2024
YY1 downregulation underlies therapeutic response to molecular targeted agentsShichao Zhou, Jingyu Zang, Mei-Chun Cai, et al.Nature Biomedical Engineering|December 10, 2025
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunityChangrui Yang, Shanni Guo, Kaiyan Ye, et al.Oncogene|February 6, 2022
SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancerLifeng Lin, Kaixuan Shi, Shaoqing Zhou, et al.Pageof 2